Table 3.
NR3C1 1F Assay 2 – CpG sites 5–1 - chr5:143,404,013–143,404,147* | |
PCR primer forward- Biotinylated | /5Biosg/ GTTGTTATTAGTAGGGGTATTGG |
PCR primer reverse | AACCACCCAATTTCTCCAATTTCTTTTC |
Pyrosequencing primer (reverse) | CAACTCCCCCACTCCAAACCC |
NR3C1 1F Assay 1 – CpG sites 6–10 - chr5:143,404,011–143,404,097* | |
PCR primer forward | AGTTTTAGAGTGGGTTTGGAG |
PCR primer reverse-Biotinylated | /5Biosg/ AAAACCACCCAATTTCTCCAATTTCTT |
Pyrosequencing primer (forward) | GAGTGGGTTTGGAGT |
BDNF IV – CpG sites 1–5 - chr11:27,701,519–27,701,826* | |
PCR primer forward | GGGTTGGAAGTGAAAATATTTGTAAA |
PCR primer reverse-Biotinylated | /5Biosg/CCCCATCAACCAAAAACTCCATTTAATCTC |
Pyrosequencing primer (forward) | GGTAGAGGAGGTATTATATGATAG |
Genomic coordinates show genomic regions amplified by PCR and are based on the UCSC Genome Browser Human Dec. 2013 (GRCh38/hg38) Assembly.